1st U.S. Drug Approved for Fibromyalgia

Important Update:

December, 2019 – FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR)
When used with CNS depressants, opioids, or in patients with lung problems.

Listen to the Podcast about this warning on the FDA site.

21 June 2007—(U.S. Food and Drug Administration press release) (.pdf) – Lyrica (pregabalin) has been approved by the U.S. Food and Drug Administration to treat fibromyalgia. It's the first drug approved in the United States to treat the condition that affects up to 6 million Americans, the agency said Thursday. People with fibromyalgia usually have chronic pain, muscle stiffness, fatigue, and sleep problems. The disorder affects more women than men, and commonly develops in early-to-middle adulthood. In the absence of a diagnostic test, doctors typically conduct physical examinations, evaluate symptoms, and rule out other possibilities, the FDA said.

Invisible Disabilities

On this page:

Note:  All links going to other websites will open in the same window. Use the Back button to return to our site.


Some common disabilities that are often unseen are

  • Addiction
  • ADHD
  • Anxiety
  • Arthritis
  • Aspergers
  • Asthma
  • Autism
  • Cancer
  • Celiac Disease
  • Chronic Fatigue
  • Chronic Pain
  • Crohn's Disease
  • Deafness
  • Depression
  • Diabetes
  • Epilepsy
  • Fibromyalgia
  • Food Allergy
  • Head Injuries
  • Heavy Metal Poisoning & Toxicity
  • High Blood Pressure
  • Hyperglycemia
  • Hypoglycemia
  • Inflammatory Bowel Disease
  • Kidney Disease
  • Learning Disability
  • Leukoencephalopathy
  • Lupus
  • Lyme Disease
  • Lymphatic Disease: Castleman's Disease and Lymphedema
  • Mental Illness
  • Mold Allergy
  • Non-Cancerous Tumours
  • Restless Legs Syndrome
  • Seasonal Affective Disorder (SAD)
  • Schizophrenia
  • Scoliosis
  • Sick Building Syndrome (SBS)
  • Sleep Apnea
  • Thoracic Outlet Syndrome
  • Thyroid Disease

For a more extensive list, see the Invisible Disabilities: List & Information (.pdf) from the UMatter at UMass initiative at the University of Massachusetts Amherst.